We are live on
!
Find out more
CGL
Clarius Group LLC Portfolio holdings
AUM
$1.75B
1-Year Est. Return
19.04%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$238M
AUM Growth
-$5.15M
(-2.1%)
Cap. Flow
-$16.6M
Cap. Flow
% of AUM
-6.98%
Top 10 Holdings %
Top 10 Hldgs %
73.68%
Holding
100
New
5
Increased
11
Reduced
37
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.86M |
| 2 |
ESL
Esterline Technologies
ESL
|
+$1.35M |
| 3 |
Vanguard Value ETF
VTV
|
+$1.25M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
+$268K |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$197K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$2.05M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
+$1.57M |
| 3 |
Apple
AAPL
|
+$1.43M |
| 4 |
Amazon
AMZN
|
+$1.26M |
| 5 |
Microsoft
MSFT
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 38.23% |
| 2 | Consumer Discretionary | 14.01% |
| 3 | Healthcare | 7.45% |
| 4 | Technology | 4.99% |
| 5 | Communication Services | 4.01% |
Similar funds
A
CB
JCM
GH
MPM
NAS
RC
LGWM
Clarius Group LLC's Q3 2017 Portfolio in Review
As of Q3 2017, Clarius Group LLC held 100 positions worth $238M, down 2.1% from $243M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Clarius Group LLC withdrew a net $16.6M in Q3 2017, closing 30 positions and reducing 37 holdings. Its most notable exit was bluebird bio, an estimated $765K position sold in full.
By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Clarius Group LLC opened a new position in Berkshire Hathaway Class A worth $1.92M.
- Clarius Group LLC's largest Q3 2017 buy was Berkshire Hathaway Class A: 7 shares worth $1.92M.
- Clarius Group LLC added most to Vanguard Value ETF in Q3 2017, an estimated $1.25M increase.
- Clarius Group LLC's biggest Q3 2017 reduction was Impinj, cutting an estimated $2.05M.
- Clarius Group LLC fully exited bluebird bio in Q3 2017, selling an estimated $765K.
- Clarius Group LLC's ten largest holdings make up 74% of its $238M portfolio in Q3 2017.
- Clarius Group LLC opened 5 new positions and closed 30 in Q3 2017.
- Clarius Group LLC's portfolio value fell 2.1% quarter-over-quarter to $238M.
Based on Clarius Group LLC's 13F filing for Q3 2017, filed 7 Nov 2017.